Home » Media

Media

International Program Spotlights the BRICs at the 2013 BIO International Convention
With one-third of all attendees international, the 2013 BIO International Convention will host a wide range of programming focused on new opportunities...
Farmers Increasingly Favor Biotech Crops
The ISAAA report, Global Status of Commercialized Biotech/GM Crops: 2012, says a record 17.3 million farmers in 28 countries are growing biotech crops on 420...

Press Releases

Genentech, Incyte Genomics Tell House Subcommittee Gene Patents Essential For Medical Progress
Jul 13 2000
WASHINGTON, D.C. (July 13, 2000) Executives from two Biotechnology Industry Organization (BIO) member companies testified today at a U.S. House Judiciary...
Genentech, Incyte Genomics Executives To Testify At House Hearing On Gene-Based Patents
Jul 12 2000
WASHINGTON, D.C. (July 12, 2000) - Executives from two Biotechnology Industry Organization (BIO) member companies will testify Thursday, July 13, at a U.S....
BIO Supports Efforts To Apply Biotechnology To Agriculture In Developing Nations
Jul 11 2000
WASHINGTON, D.C. (July 11, 2000) - The Biotechnology Industry Organization (BIO) endorses recommendations contained in a report, released today, from the U.S....
BIO Statement Regarding USDA Planting Estimates of Genetically Modified Seeds
Jun 30 2000
(Dr. Val Giddings, vice president for food and agriculture of the Biotechnology Industry Organization (BIO) issued the following statement in response to today...
BIO: House Approval Of GOP Drug Plan Represents An Important Step In Right Direction For Seniors
Jun 29 2000
WASHINGTON, D.C. (June 29, 2000) - Nancy Myers, health-care policy counsel for the Biotechnology Industry Organization (BIO), said House approval of a...
BIO Praises Congress, President for Supporting Research on Biofuels
Jun 22 2000
WASHINGTON, D.C. (June 22, 2000) --The Biotechnology Industry Organization (BIO) today applauded Congress and President Clinton for their support of research...
Missouri’s Carnahan Named BIO Governor of the Year
Jun 22 2000
WASHINGTON, D.C. (June 22, 2000) --TheBiotechnology Industry Organization (BIO) has named Missouri Gov. Mel Carnahan Governor of the Year for his support of...
BIO Says Drug Coverage, Not Price Discounts, Will Help Seniors
Jun 20 2000
WASHINGTON, D.C. (June 20, 2000) - Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on an...
BIO Testifies At Senate Committee: Private-Sector Drug Coverage Will Help Seniors, Not Price Controls
Jun 13 2000
WASHINGTON, D.C. (June 13, 2000) - Paul Abrams, CEO of NeoRx Corp., testified today on behalf of the Biotechnology Industry Organization (BIO) at a U.S. Senate...
Researchers Find No Relationship Between Bt Corn Pollen and Butterfly Larvae Mortality
Jun 5 2000
WASHINGTON (June 5, 2000) - Results of a study publishedtoday indicate that earlier laboratory reports of a relationship between mortality of butterflies and...


Biotechnology News

Idera Announces Presentation at AAD Annual Meeting Demonstrating Toll-like Receptor Antagonists Normalize Expression of Inflammatory Genes in Psoriasis Model
March 2, 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera presented new data showing that its selective Toll-like receptor antagonists normalized the gene expression of important cytokines...

Oral Apremilast Achieves Statistical Significance for the Primary Endpoint of PASI-75 in the First Phase III Study (ESTEEM 1) in Patients with Psoriasis
March 2, 2013

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from ESTEEM 1, the Company...

KYTHERA Biopharmaceuticals, Inc. Announces Positive Interim Results from Open-Label Study of ATX-101 in the Reduction of Unwanted Submental Fat (SMF) or “Double Chin”
March 2, 2013

MIAMI BEACH, Fla.--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced positive interim results from a Phase IIIb, multi-center, open-label...

‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says the Committee on Fair Drug Pricing (a.k.a. FAIR)
March 1, 2013

SAN FRANCISCO--(BUSINESS WIRE)--‘Stop Runaway Drug Pricing’ Measure Qualifies for San Francisco Ballot, says Committee on Fair Drug Pricing (a.k.a. FAIR)-Coalition of...

Gilead Sciences to Present at the Cowen & Company 33rd Annual Health Care Conference on Monday, March 4
March 1, 2013

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the Cowen and Company 33rd...